O-021 Prevention Of Bronchopulmonary Dysplasia (bpd) In Vlbw Infants With Severe Rds – A Randomised Trial Of A New Therapeutic Regimen: Abstract O-021 Table 1
نویسندگان
چکیده
منابع مشابه
O-30: Novel Interventions to Reduce ReInfection in Women with Chlamydia: A Randomised-Controlled Trial
Background: To determine if postal testing kits (PTK) and patient delivered partner therapy (PDPT) for managing sexual partners of women with Chlamydia tracho-matis, reduce re-infection rates in women, compared to partner notification by patient referral. Materials and Methods: Three hundred and thirty women testing positive for chlamydia, at clinics for genitourinary medicine, family planning ...
متن کاملComparing the Efficacy of High and Low Doses of Vitamin A in Prevention of Bronchopulmonary Dysplasia
Background Bronchopulmonary dysplasia (BPD) is one of the most common serious squeal of preterm infants. It involves approximately one quarter of infants with birth weight less than 1500 grams and 30% of less than 1000 grams. Vitamin A has been shown to reduce BPD rate. We compared efficacy of low and high doses of vitamin A for prevention of BPD in very low birth weight preterm infants. Materi...
متن کاملPreeclampsia and the Risk of Bronchopulmonary Dysplasia in VLBW Infants: A Population Based Study
BACKGROUND Preeclampsia remains a leading cause of maternal mortality and preterm delivery. Both preeclampsia and bronchopulmonary dysplasia (BPD) of prematurity are associated with impaired angiogenesis. However, the relationship between maternal preeclampsia and BPD remains controversial. This study aims to test whether or not preeclampsia is associated with development of BPD in a cohort of ...
متن کاملSystemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial
BACKGROUND Randomized controlled trials have shown that treatment of chronically ventilated preterm infants after the first week of life with dexamethasone reduces the incidence of the combined outcome death or bronchopulmonary dysplasia (BPD). However, there are concerns that dexamethasone may increase the risk of adverse neurodevelopmental outcome. Hydrocortisone has been suggested as an alte...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Disease in Childhood
سال: 2014
ISSN: 0003-9888,1468-2044
DOI: 10.1136/archdischild-2014-307384.90